Search - tctmd.com

Displaying 381 - 400 of 459

Sort: Relevancy | Date

News Daily News

HF Admissions Decline, Non-CV Hospitalizations Rise After TAVR

L.A. McKeown

March 13, 2019

News Daily News

Could PET Imaging Be the ‘Game Changer’ for Detecting and Predicting Bioprosthetic Valve Degeneration?

Michael O'Riordan

March 13, 2019

News Conference News

Flu Vaccination Tied to Less MI in Hospitalized Patients

Todd Neale

March 13, 2019

News Conference News ACC 2019

ACC 2019: A Smartwatch, Low-risk TAVR, and Bempedoic Acid Are Hoping for Luck Saint Paddy’s Day Weekend

Shelley Wood

March 11, 2019

News Conference News CRT 2019

BASILICA Leaflet Laceration Before TAVR Helps Prevent Coronary Obstruction

Yael L. Maxwell

March 04, 2019

News Conference News CRT 2019

One-Year Data on Low-Risk TAVR Continue to Show Good Safety: LRT

Yael L. Maxwell

March 04, 2019

News Daily News

FDA Provides Update on Tainted ARB Investigation, With New Impurity Found

Todd Neale

March 04, 2019

News Conference News CRT 2019

Rivaroxaban in Addition to DAPT Lowers Death, MI, Stroke in ACS, Heart Failure Patients: Meta-analysis

Yael L. Maxwell

March 03, 2019

News Conference News CRT 2019

New ALERTS Data Support Use of Implantable Cardiac Monitor in High-Risk ACS Patients—With Caveats

Yael L. Maxwell

March 03, 2019

News Daily News

TCTMD’s Top 10 Most Popular Stories for February 2019

Shelley Wood

March 01, 2019

News Daily News

ISCHEMIA Patients: High Rates of Severe-to-Moderate Ischemia, Multivessel CAD

Michael O'Riordan

March 01, 2019

News Daily News

Sex-Based Differences for Heart Failure Risk Need More Attention, Research

Yael L. Maxwell

February 28, 2019

News Daily News

Rising Number of CV-Related Maternal Deaths Spurs Need for #CardioObstetrics

Caitlin E. Cox

February 27, 2019

News Daily News

How HF Drugs Help and Harm Female Patients: A Call for Sex-Specific Reporting

Shelley Wood

February 26, 2019

News Industry News

Amgen, Cytokinetics And Servier Announce Start Of METEORIC-HF, The Second Phase 3 Clinical Trial Of Omecamtiv Mecarbil In Patients With Heart Failure

February 25, 2019

News Daily News

Breast Calcifications May Hold Important Clues for CV Risk Stratification

L.A. McKeown

February 22, 2019

News Daily News

Quality of CAD Care Varies by Type of Medicare Coverage

Todd Neale

February 20, 2019

News Daily News

Long Bouts of Sedentary Time Linked to CVD Risk in Women

Michael O'Riordan

February 20, 2019

News Daily News

New Leaflet Thrombosis After TAVR Seen Out to 3 Years: OCEAN-TAVI

Shelley Wood

February 19, 2019

Presentation JIM 2019

Functional Mitral Regurgitation in Patients with Chronic Heart Failure results of the REDUCE-FMR study

Presenter: Klaus Witte

February 15, 2019

Advertisement

HF Admissions Decline, Non-CV Hospitalizations Rise After TAVR

Could PET Imaging Be the ‘Game Changer’ for Detecting and Predicting Bioprosthetic Valve Degeneration?

Flu Vaccination Tied to Less MI in Hospitalized Patients

ACC 2019: A Smartwatch, Low-risk TAVR, and Bempedoic Acid Are Hoping for Luck Saint Paddy’s Day Weekend

BASILICA Leaflet Laceration Before TAVR Helps Prevent Coronary Obstruction

One-Year Data on Low-Risk TAVR Continue to Show Good Safety: LRT

FDA Provides Update on Tainted ARB Investigation, With New Impurity Found

Rivaroxaban in Addition to DAPT Lowers Death, MI, Stroke in ACS, Heart Failure Patients: Meta-analysis

New ALERTS Data Support Use of Implantable Cardiac Monitor in High-Risk ACS Patients—With Caveats

TCTMD’s Top 10 Most Popular Stories for February 2019

ISCHEMIA Patients: High Rates of Severe-to-Moderate Ischemia, Multivessel CAD

Sex-Based Differences for Heart Failure Risk Need More Attention, Research

Rising Number of CV-Related Maternal Deaths Spurs Need for #CardioObstetrics

How HF Drugs Help and Harm Female Patients: A Call for Sex-Specific Reporting

Amgen, Cytokinetics And Servier Announce Start Of METEORIC-HF, The Second Phase 3 Clinical Trial Of Omecamtiv Mecarbil In Patients With Heart Failure

Breast Calcifications May Hold Important Clues for CV Risk Stratification

Quality of CAD Care Varies by Type of Medicare Coverage

Long Bouts of Sedentary Time Linked to CVD Risk in Women

New Leaflet Thrombosis After TAVR Seen Out to 3 Years: OCEAN-TAVI

Functional Mitral Regurgitation in Patients with Chronic Heart Failure results of the REDUCE-FMR study

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content